DB18454InvestigationalProtein Based Therapies
AVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.
- Mechanism
- Curator reviewed
Pharmacologically active on Transforming growth factor beta-1 proprotein and Transforming growth factor beta-3 proprotein
- Also known as
- Tgf-.beta. ligand trap comprised of tgf-.beta. receptor ectodomains fused to a human fc domain (avid-200) · Tgf-beta 1/3 inhibitor avid200 · Tgfbeta receptor ectodomain-igg fc fusion protein avid200
- Code names
- AVID-200
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with AVID-200, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account